Explore
Trendline
Seaport Therapeutics to Present at Major Investor Conferences in June 2026
Seaport Therapeutics to Present at Major Investor Conferences in June 2026
Read More
Trendline
Contineum Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Contineum Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Read More
Trendline
Contineum Therapeutics to Present at 2026 Goldman Sachs Global Healthcare Conference
Contineum Therapeutics to Present at 2026 Goldman Sachs Global Healthcare Conference
Read More
Trendline
Arrowhead Pharmaceuticals to Participate in Major Healthcare Conferences in June 2026
Arrowhead Pharmaceuticals to Participate in Major Healthcare Conferences in June 2026
Read More
Trendline
Hedge Funds Bet Big on AI Stocks Amid Market Skepticism
Hedge Funds Bet Big on AI Stocks Amid Market Skepticism
Read More
Reuters
Goldman upgrades Taiwan, South Korea stocks as Asia rally intensifies
By Gregor Stuart Hunter SINGAPORE, June 3 (Reuters) - Gains for AI chipmaker stocks can continue, but risks of a pullback are growing, Goldman Sachs said in a note on Wednesday.
Read More
Trendline
Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases
Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases
Read More
Trendline
Goldman Sachs Predicts Doubling of Mobia Medical Stock Amid Stroke Recovery Market Expansion
Goldman Sachs Predicts Doubling of Mobia Medical Stock Amid Stroke Recovery Market Expansion
Read More
Reuters
Goldman Sachs lifts 12-month STOXX 600 target on resilient earnings
June 1 (Reuters) - Goldman Sachs has raised its 12-month target for STOXX 600 index to 660, the U.S. brokerage said, citing resilient corporate earnings growth despite the war in the Middle East.
Read More
Trendline
Servier Invests $2.65 Billion in Edgewise's Muscular Dystrophy Drug Development
Servier Invests $2.65 Billion in Edgewise's Muscular Dystrophy Drug Development
Read More
TheStreet
Goldman Sachs sees major shift on hedge fund chip bets
Semiconductor stocks have been among the most popular institutional trades since the AI boom reshaped Wall Street portfolios, and the momentum has continued into 2026. Data from Goldman Sachs' prime brokerage division reveal a shift in hedge fund positioning that complicates the surface-level ...
Read More
Trendline
Biohaven Targets Obesity Market to Recover from Clinical Setbacks
Biohaven Targets Obesity Market to Recover from Clinical Setbacks
Read More
